研究者詳細 - 平田　あや

論文 - 平田　あや

分割表示 53 件中 21 - 40 件目／全件表示 >>

Impact of hypertension and diabetes on the onset of chronic kidney disease in a general Japanese population

Kaneyama Akira, Hirata Aya, Hirata Takumi, Imai Yukiko, Kuwabara Kazuyo, Funamoto Mika, Sugiyama Daisuke, Okamura Tomonori

HYPERTENSION RESEARCH 2022年09月

ISSN 0916-9636

Access to Document (DOI)

Association Between Clinical Backgrounds and Malignant Progression of Suspected Intraductal Papillary Mucinous Neoplasm

Fukushima Genki, Abe Kodai, Kitago Minoru, Iwasaki Eisuke, Hirata Aya, Takemura Ryo, Ishii Ryota, Yagi Hiroshi, Abe Yuta, Hasegawa Yasushi, Fukuhara Seiichiro, Hori Shutaro, Tanaka Masayuki, Nakano Yutaka, Yokose Takahiro, Shimane Gaku, Kitagawa Yuko

PANCREAS 51 （ 6 ） 617 - 623 2022年07月

ISSN 0885-3177

Access to Document (DOI)

Serum modified high-density lipoprotein and risk of atherosclerotic cardiovascular disease in a Japanese community-based nested case-control study

Sata Mizuki, Kakino Akemi, Hirata Aya, Iida Miho, Usami Yoko, Harada Sei, Fujita Yoshiko, Kohsaka Shun, Izawa Yoshikane, Sawano Mitsuaki, Oki Koichi, Sugiyama Daisuke, Takahashi Shinichi, Takebayashi Toru, Sawamura Tatsuya, Okamura Tomonori

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 29 （ 5 ） E193 - E195 2022年05月

ISSN 2047-4873

Access to Document (DOI)

Accumulated unhealthy behaviours and insomnia in Japanese dwellers with and without cardiovascular risk factors: a cross-sectional study

Kato Suzuka, Harada Sei, Iida Miho, Kuwabara Kazuyo, Sugiyama Daisuke, Takeuchi Ayano, Sata Mizuki, Matsumoto Minako, Kurihara Ayako, Hirata Aya, Okamura Tomonori, Takebayashi Toru

BMJ OPEN 12 （ 4 ） 2022年04月

ISSN 2044-6055

Access to Document (DOI)

Prediction of Lifetime Risk of Cardiovascular Disease Deaths Stratified by Sex in the Japanese Population

Imai Yukiko, Tanaka Sachiko Mizuno, Satoh Michihiro, Hirata Takumi, Murakami Yoshitaka, Miura Katsuyuki, Waki Takashi, Hirata Aya, Sairenchi Toshimi, Irie Fujiko, Sata Mizuki, Ninomiya Toshiharu, Ohkubo Takayoshi, Ishikawa Shizukiyo, Miyamoto Yoshihiro, Ohnishi Hirofumi, Saitoh Shigeyuki, Tamakoshi Akiko, Yamada Michiko, Kiyama Masahiko, Iso Hiroyasu, Sakata Kiyomi, Nakagawa Hideaki, Okayama Akira, Ueshima Hirotsugu, Okamura Tomonori

JOURNAL OF THE AMERICAN HEART ASSOCIATION 10 （ 23 ） 2021年12月

Access to Document (DOI)

Validity Assessment of Self-reported Medication Use for Hypertension, Diabetes, and Dyslipidemia in a Pharmacoepidemiologic Study by Comparison With Health Insurance Claims (vol 31, pg 495, 2021)

Matsumoto Minako, Harada Sei, Iida Miho, Kato Suzuka, Sata Mizuki, Hirata Aya, Kuwabara Kazuyo, Takeuchi Ayano, Sugiyama Daisuke, Okamura Tomonori, Takebayashi Toru

Ｊｏｕｒｎａｌ　ｏｆ　Ｅｐｉｄｅｍｉｏｌｏｇｙ（日本疫学会） 31 （ 9 ） 520 - 521 2021年09月

ISSN 09175040

Association between environmental cadmium exposure and plasma and urinary metabolite profiles in Japanese cohort study

Ishibashi Yoshiki, Harada Sei, Eitaki Yoko, Iida Miho, Kurihara Ayako, Hirata Aya, Shibuki Takuma, Okamura Tomonori, Hirayama Akiyoshi, Sugimoto Masahiro, Soga Tomoyoshi, Tomita Masaru, Takebayashi Toru

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 50 2021年09月

ISSN 0300-5771

Change of smoking habits by introducing and spreading heated tobacco products in Japan

Harada Sei, Sata Mizuki, Matsumoto Minako, Takeuchi Ayano, Iida Miho, Kato Suzuka, Hirata Aya, Kuwabara Kazuyo, Sugiyama Daisuke, Okamura Tomonori, Takebayashi Toru

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 50 93 - 93 2021年09月

ISSN 0300-5771

Access to Document (DOI)

SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan

Nishimura Tomoyasu, Uwamino Yoshifumi, Uno Shunsuke, Kashimura Shoko, Shiraki Toshikimi, Kurafuji Toshinobu, Morita Maasa, Noguchi Masayo, Azegami Tatsuhiko, Yamada-Goto Nobuko, Murai-Takeda Ayano, Yokoyama Hirokazu, Kuwabara Kazuyo, Kato Suzuka, Matsumoto Minako, Hirata Aya, Iida Miho, Harada Sei, Ishizaka Tamami, Misawa Kana, Murata Mitsuru, Saya Hideyuki, Amagai Masayuki, Kitagawa Yuko, Takeuchi Tsutomu, Mori Masaaki, Takebayashi Toru, Hasegawa Naoki

Japanese Journal of Medicine （一般社団法人日本内科学会） 60 （ 16 ） 2569 - 2575 2021年08月

ISSN 09182918

Objective To consider effective measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in medical institutions, this study estimated the SARS-CoV-2 infection rate among healthcare workers (HCWs) in Tokyo, Japan, and determined the specific findings for mild coronavirus disease 2019 (COVID-19) cases. Methods This study analyzed the results of serologic tests to detect immunoglobulin G antibodies against SARS-CoV-2 and evaluated the demographic and clinical characteristics of the faculty and HCWs at a Tokyo medical institution in August 2020. The demographic and clinical characteristics of participants with antibody-positive results were compared to those of participants with antibody-negative results. Materials This study recruited 2,341 faculty and HCWs at a Tokyo medical institution, 21 of whom had a COVID-19 history. Results Of the 2,320 participants without a COVID-19 history, 20 (0.862%) had positive serologic test results. A fever and dysgeusia or dysosmia occurred with greater frequency among the participants with positive test results than in those with negative results [odds ratio (OR), 5.475; 95% confidence interval (CI), 1.960-15.293 and OR, 24.158; 95% CI, 2.693-216.720, respectively]. No significant difference was observed in the positivity rate between HCWs providing medical care for COVID-19 patients using adequate protection and other HCWs (OR, 2.514; 95% CI, 0.959-6.588). Conclusion To reduce the risk of COVID-19 spread in medical institutions, faculty and HCWs should follow standard and necessary transmission-based precautions, and those with a fever and dysgeusia or dysosmia should excuse themselves from work as soon as possible.

Reliability of urinary charged metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry

Ishibashi Yoshiki, Harada Sei, Takeuchi Ayano, Iida Miho, Kurihara Ayako, Kato Suzuka, Kuwabara Kazuyo, Hirata Aya, Shibuki Takuma, Okamura Tomonori, Sugiyama Daisuke, Sato Asako, Amano Kaori, Hirayama Akiyoshi, Sugimoto Masahiro, Soga Tomoyoshi, Tomita Masaru, Takebayashi Toru

SCIENTIFIC REPORTS 11 （ 1 ） 2021年04月

ISSN 2045-2322

Access to Document (DOI)

Electrocardiographic Left Atrial Abnormality and B-Type Natriuretic Peptide in a General Japanese Population: NIPPON DATA2010

Shoji Satoshi, Kadota Aya, Ueshima Hirotsugu, Okayama Akira, Miura Katsuyuki, for the NIPPON DATA2010 Research Group, Kohsaka Shun, Sawano Mitsuaki, Okamura Tomonori, Hirata Aya, Sugiyama Daisuke, Ohkubo Takayoshi, Nakamura Yasuyuki, Watanabe Makoto

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ（一般社団法人日本動脈硬化学会） 28 （ 1 ） 34 - 43 2021年

ISSN 1340-3478

Aims: P-wave terminal force in lead V1 (PTFV1) is an electrocardiogram marker of increased left atrial pressure and may be a noninvasive and early detectable marker for future cardiovascular events in the general population compared to serum B-type natriuretic peptide (BNP) concentration. The clinical significance of PTFV1 in the contemporary general population is an area of unmet need. We aimed to demonstrate the correlation between PTFV1 and BNP concentrations in a contemporary representative Japanese population. Methods: Among 2,898 adult men and women from 300 randomly selected districts throughout Japan (NIPPON DATA2010), we analyzed 2,556 participants without cardiovascular disease (stroke, myocardial infarction, and atrial fibrillation). Elevated BNP was defined as a value of ≥ 20 pg/mL based on the definition from the Japanese Circulation Society guidelines. Results: In total, 125 (4.9%) participants had PTFV1. Participants with PTFV1 were older with a higher prevalence of hypertension, major electrocardiographic findings, and elevated BNP concentrations (13.5 [6.9, 22.8] versus 7.8 [4.4, 14.5] pg/mL; P＜0.001). After adjustment for confounders, PTFV1 was correlated with elevated BNP (odds ratio, 1.66; 95% confidence interval, 1.05–2.62; P=0.030). This correlation was consistent among various subgroups and was particularly evident in those aged ＜65 years or those without a history of hypertension. Conclusions: In the contemporary general population cohort, PTFV1 was independently related to high BNP concentration. PTFV1 may be an alternative marker to BNP in identifying individuals at a higher risk of future cardiovascular events in the East Asian population.

Access to Document (DOI)

Changes in smoking habits and behaviors following the introduction and spread of heated tobacco products in Japan and its effect on FEV1 decline: a longitudinal cohort study

Harada Sei, Ishibashi Yoshiki, Sugiyama Daisuke, Okamura Tomonori, Takebayashi Toru, Sata Mizuki, Matsumoto Minako, Iida Miho, Takeuchi Ayano, Kato Suzuka, Hirata Aya, Kuwabara Kazuyo, Shibuki Takuma

Ｊｏｕｒｎａｌ　ｏｆ　Ｅｐｉｄｅｍｉｏｌｏｇｙ（日本疫学会） 2021年

ISSN 0917-5040

Background: Heated tobacco product (HTP) use in Japan has rapidly increased. Despite this rapid spread, little is known about the health effects of HTP use. We conducted a longitudinal cohort study to investigate the change in smoking habits following the spread of HTP use and its effect on forced expiratory volume in one second (FEV1) decline.Methods: Participants consisted of a resident population (n=2,612, aged 67.7) with FEV1 measurement in 2012-2014 and 2018-2019, and a worksite population (n=722, aged 49.3) without FEV1 data. Participants were categorized as never, past and combustible cigarette-only smokers, and HTP-only and dual users. The association between smoking group and the change in smoking consumption for 5.6 years was examined. Differences in annual FEV1 change between smoking groups were examined in the resident population.Results: Prevalence of HTP-only and dual users in 2018-2019 was 0.8% and 0.6% in the resident population, and 5.0% and 1.9% in the worksite population, respectively. The overall number of tobacco products smoked/used increased in dual users compared to baseline, but not in others. Annual FEV1 decline in dual users tended to be greater than that in cigarette-only smokers (16 mL/yr [95% CI: -34, 2] after full adjustment). Participants switching to HTP-only use 1.7 years before had a similar FEV1 decline as cigarette-only smokers.Conclusions: HTP use, including dual use, is prevalent even in a rural region of Japan. Dual users appear to smoke/use tobacco products more and have a greater FEV1 decline. Tobacco policy should consider dual use as high-risk.

Access to Document (DOI)

Relationship Between Non-fasting Triglycerides and Cardiovascular Disease Mortality in a 20-year Follow-up Study of a Japanese General Population: NIPPON DATA90

Hirata Aya, Kondo Keiko, Miura Katsuyuki, Okayama Akira, Ueshima Hirotsugu, Okamura Tomonori, Hirata Takumi, Sugiyama Daisuke, Ohkubo Takayoshi, Okuda Nagako, Kita Yoshikuni, Hayakawa Takehito, Kadota Aya

Ｊｏｕｒｎａｌ　ｏｆ　Ｅｐｉｄｅｍｉｏｌｏｇｙ（日本疫学会） 2021年

ISSN 0917-5040

Background: Non-fasting triglycerides (TG) are considered a better predictor of cardiovascular disease (CVD) than fasting TG. However, the effect of non-fasting TG on fatal CVD events remains unclear. In the present study, we aimed to explore the relationship between non-fasting TG and CVD mortality in a Japanese general population.Methods: A total of 6,831 participants without a history of CVD, in which those who had a blood sampling over 8 hours or more after a meal were excluded, were followed for 18.0 years. We divided participants into seven groups according to non-fasting TG levels: ≤59 mg/dL, 60–89 mg/dL, 90–119 mg/dL, 120–149 mg/dL, 150–179 mg/dL, 180–209 mg/dL, and ≥210 mg/dL, and estimated the multivariable-adjusted hazard ratios (HRs) of each TG group for CVD mortality after adjusting for potential confounders, including high density lipoprotein cholesterol. Additionally, we performed analysis stratified by age <65 and ≥65 years.Results: During the follow-up period, 433 deaths due to CVD were detected. Compared with a non-fasting TG of 150–179 mg/dL, non-fasting TG ≥210 mg/dL was significantly associated with increased risk for CVD mortality (HR 1.56: 95% CI, 1.01–2.41). Additionally, lower levels of non-fasting TG were also significantly associated with increased risk for fatal CVD. In participants aged ≥65 years, lower levels of non-fasting TG had a stronger impact on increased risk for CVD mortality, while higher levels of non-fasting TG had a stronger impact in those aged <65 years.Conclusion: In a general Japanese population, we observed a U-shaped association between non-fasting TG and fatal CVD events.

Access to Document (DOI)

Impact of resting heart rate on cardiovascular mortality according to serum albumin levels in a 24-year follow-up study on a general Japanese population: NIPPON DATA80

Liu Yiwei, Okayama Akira, Ueshima Hirotsugu, Hirata Aya, Okamura Tomonori, Sugiyama Daisuke, Hirata Takumi, Kadota Aya, Kondo Keiko, Ohkubo Takayoshi, Miura Katsuyuki

Ｊｏｕｒｎａｌ　ｏｆ　Ｅｐｉｄｅｍｉｏｌｏｇｙ（日本疫学会） 2021年

ISSN 0917-5040

BackgroundElevated resting heart rate (RHR) is associated with an increased risk for cardiovascular disease (CVD) and all-cause mortality. However, the findings of cohort studies differed. Thus, the impact of RHR on CVD mortality might be different according to the background of the population. Therefore, we examined the relationship of RHR and CVD mortality according to serum ALB levels in a Japanese general population.MethodsIn total, 8363 individuals without a history of CVD were followed-up for 24.0 years. The participants were divided into four groups according to the quartiles of RHR (Q1–Q4), and they were further classified into the high and low ALB groups based on a median value of 44 g/L. We estimated the multivariable-adjusted hazard ratios (HRs) of CVD mortality in each RHR group based on ALB levels, and the interaction between RHR and ALB groups on CVD mortality was evaluated.ResultsWe found no significant association between RHR and CVD mortality. However, the Q4 of RHR was significantly associated with an increased risk for CVD mortality (HR: 1.27 [95% confidence interval, CI: 1.02–1.57]) in participants with a low ALB level. Meanwhile, the Q4 of RHR was significantly correlated with a decreased risk for CVD morality in those with a high ALB level (HR: 0.61 [95% CI: 0.47–0.79]) after adjusting for covariates. A significant interaction between RHR and ALB for CVD mortality was shown (p<0.001).ConclusionsThe impact of RHR on CVD mortality differed according to ALB levels in a general Japanese population.

Access to Document (DOI)

Association of the Estimated Coronary Artery Incidence Risk According to the Japan Atherosclerosis Society Guidelines 2017 with Cardio-Ankle Vascular Index

Sata Mizuki, Matsumoto Minako, Kurihara Ayako, Takebayashi Toru, Okamura Tomonori, Harada Sei, Sugiyama Daisuke, Kuwabara Kazuyo, Hirata Aya, Takeuchi Ayano, Iida Miho, Kato Suzuka

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ（一般社団法人日本動脈硬化学会） 2021年

ISSN 1340-3478

Aims: The categories in the comprehensive lipid and risk management guidelines were proposed by the Japan Atherosclerosis Society (JAS Guidelines 2017), which adopted the estimated 10 year absolute risk of coronary artery disease (CAD) incidence in the Suita score. We examined whether those categories were concordant with the degree of arterial stiffness. Methods: In 2014, the cardio-ankle vascular index (CAVI), an arterial stiffness parameter, was measured in 1,972 Japanese participants aged 35–74 years in Tsuruoka City, Yamagata Prefecture, Japan. We examined the mean CAVI and the proportion and odds ratios (ORs) of CAVI ≥ 9.0 on the basis of the following three management classifications using the analysis of variance and logistic regression: "Category I (Low risk)," "Category II (Middle risk)," and "Category III (High risk)." Results: The mean CAVI and proportion of CAVI ≥ 9.0 were 8.6 and 34.8% among males and 8.1 and 18.3% among females, respectively. The mean CAVI and proportion of CAVI ≥ 9.0 were associated with an estimated 10 year absolute risk for CAD among males and females, excluding High risk for females. These results were similar to the management classification by the guideline: the multivariable-adjusted ORs (95% confidence intervals) of CAVI ≥ 9.0 among Category II and Category III compared with those among Category I were 2.96 (1.61–5.43) and 7.33 (4.03–13.3) for males and 3.99 (2.55–6.24) and 3.34 (2.16–5.16) for females, respectively. Conclusions: The risk stratification, which was proposed in the JAS Guidelines 2017, is concordant with the arterial stiffness parameter.

Access to Document (DOI)

Control of a Nosocomial Outbreak of COVID-19 in a University Hospital

Harada Sei, Uno Shunsuke, Ando Takayuki, Iida Miho, Takano Yaoko, Ishibashi Yoshiki, Uwamino Yoshifumi, Nishimura Tomoyasu, Takeda Ayano, Uchida Sho, Hirata Aya, Sata Mizuki, Matsumoto Minako, Takeuchi Ayano, Obara Hideaki, Yokoyama Hirokazu, Fukunaga Koichi, Amagai Masayuki, Kitagawa Yuko, Takebayashi Toru, Hasegawa Naoki

OPEN FORUM INFECTIOUS DISEASES 7 （ 12 ） 2020年12月

ISSN 2328-8957

Access to Document (DOI)

The relationship between serum levels of LOX-1 ligand containing ApoAI as a novel marker of dysfunctional HDL and coronary artery calcification in middle-aged Japanese men

Hirata Aya, Kakino Akemi, Okamura Tomonori, Usami Yoko, Fujita Yoshiko, Kadota Aya, Fujiyoshi Akira, Hisamatsu Takashi, Kondo Keiko, Segawa Hiroyoshi, Sawamura Tatsuya, Miura Katsuyuki, Ueshima Hirotsugu

ATHEROSCLEROSIS 313 20 - 25 2020年11月

ISSN 0021-9150

Access to Document (DOI)

Estimated 24 h Urinary Sodium-to-Potassium Ratio Is Related to Renal Function Decline: A 6-Year Cohort Study of Japanese Urban Residents

Hattori Hiroko, Hirata Aya, Kubo Sachimi, Nishida Yoko, Nozawa Miki, Kawamura Kuniko, Hirata Takumi, Kubota Yoshimi, Sata Mizuki, Kuwabara Kazuyo, Higashiyama Aya, Kadota Aya, Sugiyama Daisuke, Miyamatsu Naomi, Miyamoto Yoshihiro, Okamura Tomonori

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 17 （ 16 ） 2020年08月

Access to Document (DOI)

Validity Assessment of Self-reported Medication Use for Hypertension, Diabetes, and Dyslipidemia in a Pharmacoepidemiologic Study by Comparison With Health Insurance Claims

Matsumoto Minako, Okamura Tomonori, Takebayashi Toru, Harada Sei, Iida Miho, Kato Suzuka, Sata Mizuki, Hirata Aya, Kuwabara Kazuyo, Takeuchi Ayano, Sugiyama Daisuke

Ｊｏｕｒｎａｌ　ｏｆ　Ｅｐｉｄｅｍｉｏｌｏｇｙ（日本疫学会） 2020年

ISSN 0917-5040

Background: Although self-reported questionnaires are widely employed in epidemiologic studies, their validity has not been sufficiently assessed. The aim of this study was to evaluate the validity of a self-reported questionnaire on medication use by comparison with health insurance claims and to identify individual determinants of discordance in the Tsuruoka Metabolomics Cohort Study.Methods: Participants were 2,472 community-dwellers aged 37 to 78 years from the Tsuruoka Metabolomics Cohort Study. Information on lifestyle and medications was collected through a questionnaire. Sensitivity and specificity were determined using health insurance claims from November 2014 to March 2016, which were used as a standard. Potential determinants of discordance were assessed using multivariable logistic regression.Results: The self-reported questionnaire on medication use showed high validity. Sensitivity and specificity were 0.95 (95% CI, 0.93–0.96) and 0.97 (95% CI, 0.96–0.98) for antihypertensive medications, 0.94 (95% CI, 0.91–0.97) and 0.98 (95% CI, 0.98–0.99) for diabetes medications, and 0.84 (95% CI, 0.82–0.87) and 0.98 (95% CI, 0.97–0.99) for dyslipidemia medications, respectively. Males without high education and those who currently smoke cigarettes were found to be associated with discordant reporting which affected sensitivity, especially those with medication use for dyslipidemia.Conclusions: In this population-based cohort study, we found that the self-reported questionnaire on medication use was a valid measure to capture regular medication users. Sensitivity for dyslipidemia medications was lower than those for the other medications. Type of medication, sex, education years, and smoking status influenced discordance, which affected sensitivity in self-reporting.

Access to Document (DOI)

Physique at Birth and Cardiovascular Disease Risk Factors in Japanese Urban Residents: the KOBE Study

Umemoto Kaori, Kuwabara Kazuyo, Miyazaki Junji, Kadota Aya, Iida Miho, Sugiyama Daisuke, Miyamatsu Naomi, Miyamoto Yoshihiro, Okamura Tomonori, Kubo Sachimi, Nishida Yoko, Higashiyama Aya, Kawamura Kuniko, Kubota Yoshimi, Hirata Takumi, Hirata Aya, Sata Mizuki

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ（一般社団法人日本動脈硬化学会） 2020年

ISSN 1340-3478

Aim: This study investigated the relationship between birth physique and cardiovascular risk factors in Japanese urban residents aged 40 years and more. Methods: A self-administered questionnaire on birth physique was performed among 624 individuals (165 men and 459 women) who participated in the KOBE study. We examined whether self-reported birth physique and available recorded birth weights matched for 72 participants. Then the association between birth physique and risk factors for all participants was examined by gender. Body size at birth in the questionnaire (large, medium, small) was set as an exposure and laboratory values from the baseline survey (2010-2011) were used as outcomes. Results: Mean (standard deviation) recorded birth weight of 72 participants was 3665 (318), 3051 (300), and 2653 (199) g, in the large, medium, and small group, respectively. In the analysis for all participants, odds ratio for having both hypertension and impaired glucose tolerance were significantly higher in the small versus large birth weight group, which was 7.42 (95% CI 1.75–31.50) for men and 4.44 (95% CI 1.14–17.30) for women after adjusting for age, body mass index, smoking/alcohol/exercise habits, and menstrual status in women. Similar results were observed in participants with recorded birth weight. Conclusions: The present study indicates that individuals with small physique at birth might be at higher risk for hypertension and impaired glucose tolerance in middle age compared to those with large birth weight.

Access to Document (DOI)

　前のページ - 次のページ　

平田 あや

論文 - 平田 あや

平田　あや

論文 - 平田　あや